Implantica AG (publ) announces that Dr. med. Zehetner, Prof. (USC) from Switzerland, presented Klinik Beau-Site's RefluxStop results at Digestive Disease Week (DDW) 6-9 May, in Chicago, U.S., the world's premier meeting for gastrointestinal professionals. Dr. med.

Jörg Zehetner, Prof. (USC), surgeon at the Hirslanden Klinik Beau-Site Bern, Switzerland, highlighted the unique advantages of the RefluxStop™ therapy in the reflux patient population that have Ineffective Esophageal Motility (IEM), a disorder that often causes swallowing difficulties and pain, a patient group which does not have any optimal treatment options today. Encircling the food passageway as in existing treatments often worsen these patients' swallowing difficulties and Dr. Zehetner sees RefluxStop™ as a potential major breakthrough for these patients. Despite the IEM condition in this group of 20 patients, all patients are showing complete resolution or significant improvement of reflux symptoms.